Stericycle Inc. (NASDAQ:SRCL) – Investment analysts at Oppenheimer Holdings cut their FY2017 EPS estimates for Stericycle in a research report issued on Monday. Oppenheimer Holdings analyst S. Schneeberger now forecasts that the brokerage will post earnings of $4.78 per share for the year, down from their prior estimate of $5.20.

A number of other research analysts have also recently commented on SRCL. Zacks Investment Research cut Stericycle from a “buy” rating to a “hold” rating in a research report on Thursday, July 14th. Imperial Capital decreased their price target on Stericycle from $100.00 to $95.00 and set an “in-line” rating on the stock in a research report on Thursday, May 26th. Royal Bank Of Canada reaffirmed a “sell” rating on shares of Stericycle in a research note on Thursday, May 26th. Northcoast Research lowered Stericycle from a “buy” rating to a “neutral” rating in a research note on Tuesday. Finally, Jefferies Group reaffirmed a “buy” rating and issued a $125.00 price objective (down from $140.00) on shares of Stericycle in a research note on Friday, July 29th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $110.32.

Shares of Stericycle (NASDAQ:SRCL) traded up 1.18% during mid-day trading on Tuesday, hitting $77.92. The stock had a trading volume of 875,322 shares. Stericycle has a 1-year low of $76.76 and a 1-year high of $151.57. The firm has a market capitalization of $6.63 billion, a PE ratio of 27.43 and a beta of 0.27. The stock’s 50-day moving average is $84.76 and its 200-day moving average is $102.60.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting analysts’ consensus estimates of $1.18. The company earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. Stericycle’s revenue was up 24.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.14 EPS.

Several institutional investors have recently bought and sold shares of the company. Macquarie Group Ltd. raised its position in Stericycle by 62.5% in the second quarter. Macquarie Group Ltd. now owns 43,150 shares of the company’s stock worth $4,492,000 after buying an additional 16,600 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Stericycle during the second quarter worth $357,000. Kentucky Retirement Systems acquired a new stake in shares of Stericycle during the second quarter worth $752,000. Mason Street Advisors LLC acquired a new stake in shares of Stericycle during the second quarter worth $1,191,000. Finally, Northwestern Mutual Wealth Management Co. increased its stake in shares of Stericycle by 42.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,664 shares of the company’s stock worth $277,000 after buying an additional 795 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

In related news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the transaction, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by corporate insiders.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.